Current status and future prospects of human gene therapy

Pediatrics International

Volumn 38, Issue 2, 1996, Pages 176-181

  Shimada, Takashi ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

Cancer; Gene therapy; Gene transfer; Genetic disease; Retroviral vector

Indexed keywords

ADENOSINE DEAMINASE; VIRUS VECTOR;

ADENO ASSOCIATED VIRUS; ADENOVIRUS; ARTERY DISEASE; CANCER; CLINICAL TRIAL; COMBINED IMMUNODEFICIENCY; ENZYME DEFICIENCY; GENE THERAPY; GENETIC DISORDER; HERPES SIMPLEX VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PRIORITY JOURNAL; RETROVIRUS; REVIEW; RHEUMATOID ARTHRITIS; TECHNIQUE;

ADENOSINE DEAMINASE; CHILD, PRESCHOOL; FEMALE; FORECASTING; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HUMANS; NEOPLASMS; RETROVIRIDAE;

EID: 0029868033     PISSN: 13288067     EISSN: 1442200X     Source Type: Journal    
DOI: 10.1111/j.1442-200X.1996.tb03465.x     Document Type: Review

References (27)

1. Brenner MK, Rill DR. Gene marking to determine whether autologous marrow infusion restores long-term haemopoiesis in cancer patients. Lancet 1993; 342: 1134–7.
2. Rosenberg SA, Aebersold P., Cornetta K. et al. Gene transfer into humans—immunotherapy of patients with advanced melanoma, using tumor-infiltrating lymphocytes modified by retroviral gene transduction. N. Engl. J. Med. 1990; 323: 570–8.
3. Shimotohno K., Temin HM. Formation of infectious progeny virus after insertion of herpes simplex thymidine kinase gene into DNA of an avian retrovirus. Cell 1981; 26: 67–77.
4. Miller AD. Retrovirus packaging cells. Hum. Gene Ther. 1993; 1: 5–14.
5. Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990; 61: 759–67.
6. Donahue RE, Kessler SW, Bodine D. et al. Helper virus induced T cell lymphoma in nonhuman primates after retroviral mediated gene transfer. J. Exp. Med. 1992; 176: 1125–35.
7. Markowitz D., Goff S., Bank A. A safe packaging line for gene transfer: Separating viral genes on two different plasmids. J. Virol. 1988; 62: 1120–4.
8. Miller DG, Adam MA, Miller AD. Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection. Mol. Cell. Biol. 1990; 10: 4239–42.
9. Berkner KL. Expression of heterologous sequences in adenoviral vectors. Curr. Top. Microbiol. Immunol. 1992; 158: 39–66.
10. Rosenfeld MA, Siegfried W., Yoshimura K. et al. Adenovirus-mediated transfer of a recombinant alpha I-antitrypsin gene to the lung epithelium in vivo. Science 1991; 252: 431–4.
11. Rosenfeld MA, Yoshimura K., Trapnell BC et al. In vivo transfer of the human cystic fibrosis transmembrane conductance regulator gene to the airway epithelium. Cell 1992; 68: 143–55.
12. Dai Y., Schwarz EM, Gu D., Zhang W., Sarvetnick N., Verma IM. Cellular and humoral immune response to adenoviral vectors containing factor IX gene: Tolerization of factor IX and vector antigens allows for long-term expression. Proc. Natl Acad. Sci. USA 1995; 92: 1401–5.
13. During MJ, Naegele JR, O'Malley KL, Geller AI. Long-term behavioral recovery in Parkinsonian rats by an HSV vector expressing tyrosine hydroxylase. Science 1994; 266: 1399–403.
14. Kotin RM. Prospects for the use of adno-associated virus as a vector for human gene therapy. Hum. Gene Ther. 1994; 5: 793–801.
15. Shimada T., Fujii H., Mitsuya H., Nienhuis AW. Targeted and highly efficient gene transfer into CD4 + cells by a recombinant human immunodeficiency virus retroviral vector. J. Clin. Invest. 1991; 88: 1043–7.
16. Blaese RM, Culver KW, Miller AD et al. T lymphocyte-directed gene therapy for ADA-SCID: Initial trial results after 4 years. Science 1995; 270: 475–80.
17. Kohn DB, Weinberg KI, Nolta JA et al. Engraftment of gene-modified umbilical cord blood cells in neonates with adenosine deaminase deficiency. Nature Med. 1995; 1: 1017–23.
18. Grossman M., Raper SE, Kozarsky K. et al. Successful ex vivo gene therapy directed to liver in a patient with familial hypercholesterolaemia. Nature Genet. 1994; 6: 335–41.
19. Crystal RG, McElvaney NG, Rosenfeld MA et al. Administration of an adenovirus containing the human CFTR cDNA to the respiratory tract of individuals with cystic fibrosis. Nature Genet. 1994; 8: 42–51.
20. Walsh CE, Grompe M., Vanin E. et al. A functionally active retrovirus vector for gene therapy in Fanconi anemia group C. Blood 1994; 84: 453–9.
21. Schiffmann R., Medin JA, Ward JM, Stahl S., Cottier-Fox M., Karlsson S. Transfer of the human glucocerebrosidase gene into hematopoietic stem cells of nonablated recipients: Successful engraftment and long-term expression of the transgene. Blood 1995; 86: 1218–27.
22. Dranoff G., Jaffee E., Lazenby A. et al. Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity. Proc. Natl Acad. Sci. USA 1993; 90: 3539–43.
23. Culver KW, Ram Z., Wallbridge S., Ishii H., Oldfield EH, Blaese RM. In vivo transfer with retroviral vector-producer cells for treatment of experimental brain tumors. Science 1992; 256: 1550–2.
24. Tepper RI, Mule JJ. Experimental and clinical studies of cytokine gene modified tumor cells. Hum. Gene Ther. 1994; 5: 153–64.
25. Plautz GE, Yang Z., Wu B., Gao X., Huang L., Nabel GJ. Immunotherapy of malignancy by in vivo gene transfer into tumors. Proc. Natl Acad. Sci. USA 1993; 90: 4645–9.
26. Kasahara N., Dozy AM, Kan YW. Tissue-specific targeting of retroviral vectors through ligand-receptor interactions. Science 1994; 266: 1373–6.
27. Somia NV, Zoppe M., Verma IM. Generation of targeted retroviral vectors by using single-chain variable fragment: An approach to in vivo gene delivery. Proc. Natl Acad Sci. USA 1995; 92: 7570–4.